GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Halberd Corp (OTCPK:HALB) » Definitions » Interest Expense

Halberd (Halberd) Interest Expense : $ Mil (TTM As of Jul. 2023)


View and export this data going back to 2009. Start your Free Trial

What is Halberd Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Halberd's interest expense for the six months ended in Jul. 2023 was $ -0.01 Mil. Halberd does not have enough years/quarters to calculate its interest expense for the trailing twelve months (TTM) ended in Jul. 2023.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Halberd's Operating Income for the six months ended in Jul. 2023 was $ -0.45 Mil. Halberd's Interest Expense for the six months ended in Jul. 2023 was $ -0.01 Mil. Halberd did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.


Halberd Interest Expense Historical Data

The historical data trend for Halberd's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Halberd Interest Expense Chart

Halberd Annual Data
Trend Jul08 Jul22 Jul23
Interest Expense
-0.02 -0.01 -0.01

Halberd Semi-Annual Data
Jul08 Jul22 Jul23
Interest Expense -0.02 -0.01 -0.01

Halberd Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.


Halberd  (OTCPK:HALB) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Halberd's Interest Expense for the six months ended in Jul. 2023 was $-0.01 Mil. Its Operating Income for the six months ended in Jul. 2023 was $-0.45 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in Jul. 2023 was $0.15 Mil.

Halberd's Interest Coverage for the quarter that ended in Jul. 2023 is calculated as

Halberd did not have earnings to cover the interest expense.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.


Halberd (Halberd) Business Description

Traded in Other Exchanges
N/A
Address
P.O. Box 25, Jackson Center, PA, USA, 16133
Halberd Corp is a research-based biotechnology company seeking to discover and develop medical treatments for a range of diseases. The Company's extracorporeal treatment is designed to treat hard-to-cure blood-borne, neurologic and infectious diseases. The Company's patented methodology removes the appropriate bodily fluid from the patient, in a continuous fashion, like dialysis, or in a batch process, like blood sample testing.
Executives
John Christopher Maddox director, 10 percent owner, officer: President, COO, Treasurer and, other: Interim CFO 10755 VERNON, HUNTINGTON WOODS MI 48070
Mark Sven Lundquist director, 10 percent owner, officer: CEO, Secretary and Director 24655 TUDOR LANE, FRANKLIN MI 48025
Cocco Nicholas A. Jr. director 50104 N. JIMMY COURT, CHESTERFIELD MI 48047-1898
Leland Michael Thomas director 280 LASALLE PLACE, GROSSE POINTE FARMS MI 88236